170 related articles for article (PubMed ID: 38769503)
21. TGFβ-signaling in squamous cell carcinoma occurring in recessive dystrophic epidermolysis bullosa.
Knaup J; Gruber C; Krammer B; Ziegler V; Bauer J; Verwanger T
Anal Cell Pathol (Amst); 2011; 34(6):339-53. PubMed ID: 22002724
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow transplant with post-transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts.
Ebens CL; McGrath JA; Tamai K; Hovnanian A; Wagner JE; Riddle MJ; Keene DR; DeFor TE; Tryon R; Chen M; Woodley DT; Hook K; Tolar J
Br J Dermatol; 2019 Dec; 181(6):1238-1246. PubMed ID: 30843184
[TBL] [Abstract][Full Text] [Related]
23. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
Newman C; Wagner RF; Tyring SK; Spigel GT
J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
[TBL] [Abstract][Full Text] [Related]
24. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H
Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366
[TBL] [Abstract][Full Text] [Related]
25. Good clinical response to cemiplimab in a young patient with locally advanced cutaneous squamous cell carcinoma on preexisting recessive dystrophic epidermolysis bullosa.
Ciurescu D; Condruz S; Irimie M
Acta Dermatovenerol Alp Pannonica Adriat; 2024 May; 33(3):actaapa.2024.14. PubMed ID: 38808531
[TBL] [Abstract][Full Text] [Related]
26. The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
Subramaniam KS; Antoniou MN; McGrath JA; Lwin SM
Br J Dermatol; 2022 Apr; 186(4):609-619. PubMed ID: 34862606
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas.
Illmer J; Zauner R; Piñón Hofbauer J; Wimmer M; Gruner S; Ablinger M; Bischof J; Dorfer S; Hainzl S; Tober V; Bergson S; Sarig O; Samuelov L; Guttmann-Gruber C; Shalom-Feuerstein R; Sprecher E; Koller U; Laimer M; Bauer JW; Wally V
Br J Dermatol; 2023 Dec; 190(1):80-93. PubMed ID: 37681509
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
Ng YZ; Pourreyron C; Salas-Alanis JC; Dayal JH; Cepeda-Valdes R; Yan W; Wright S; Chen M; Fine JD; Hogg FJ; McGrath JA; Murrell DF; Leigh IM; Lane EB; South AP
Cancer Res; 2012 Jul; 72(14):3522-34. PubMed ID: 22564523
[TBL] [Abstract][Full Text] [Related]
29. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey.
Eng VA; Solis DC; Gorell ES; Choi S; Nazaroff J; Li S; de Souza MP; Murrell DF; Marinkovich MP; Tang JY
J Am Acad Dermatol; 2021 Nov; 85(5):1161-1167. PubMed ID: 32199895
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
Weber F; Bauer JW; Sepp N; Högler W; Salmhofer W; Hintner H; Fritsch P
Acta Derm Venereol; 2001; 81(3):189-92. PubMed ID: 11558875
[TBL] [Abstract][Full Text] [Related]
31. Fibrosis as a Risk Factor for Cutaneous Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa: A Systematic Review.
de Azevedo BLR; Roni GM; Torrelio RMF; da Gama-de-Souza LN
J Pediatr Genet; 2023 Jun; 12(2):97-104. PubMed ID: 37090823
[TBL] [Abstract][Full Text] [Related]
32. High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion.
Pourreyron C; Chen M; McGrath JA; Salas-Alanis JC; South AP; Leigh IM
Br J Dermatol; 2014 Jun; 170(6):1256-65. PubMed ID: 24641191
[TBL] [Abstract][Full Text] [Related]
33. A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
Tang JY; Marinkovich MP; Lucas E; Gorell E; Chiou A; Lu Y; Gillon J; Patel D; Rudin D
Orphanet J Rare Dis; 2021 Apr; 16(1):175. PubMed ID: 33849616
[TBL] [Abstract][Full Text] [Related]
34. Patent landscape of molecular and cellular targeted therapies for recessive dystrophic epidermolysis bullosa.
Dourado Alcorte M; Sogayar MC; Demasi MA
Expert Opin Ther Pat; 2019 May; 29(5):327-337. PubMed ID: 31017019
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa.
Feinstein JA; Bruckner AL; Chastek B; Anderson A; Roman J
Orphanet J Rare Dis; 2022 Sep; 17(1):367. PubMed ID: 36175960
[TBL] [Abstract][Full Text] [Related]
36. A cancer stem cell-like phenotype is associated with miR-10b expression in aggressive squamous cell carcinomas.
Wimmer M; Zauner R; Ablinger M; Piñón-Hofbauer J; Guttmann-Gruber C; Reisenberger M; Lettner T; Niklas N; Proell J; Sajinovic M; De Souza P; Hainzl S; Kocher T; Murauer EM; Bauer JW; Strunk D; Reichelt J; Mellick AS; Wally V
Cell Commun Signal; 2020 Apr; 18(1):61. PubMed ID: 32276641
[TBL] [Abstract][Full Text] [Related]
37. Squamous cell carcinoma in recessive dystrophic epidermolysis bullosa, presenting as an ulcer that appears to be filled with granulation tissue.
Kalisiak MS; Edwards D; Lin AN
J Cutan Med Surg; 2003; 7(3):229-31. PubMed ID: 12704532
[TBL] [Abstract][Full Text] [Related]
38. Role of transforming growth factor-β1 in recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
Twaroski K; Chen W; Pickett-Leonard M; Tolar J
Exp Dermatol; 2021 May; 30(5):664-675. PubMed ID: 33595864
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and Outcome of Squamous Cell Carcinoma in Epidermolysis Bullosa in Australia and New Zealand.
Kim M; Li M; Intong-Wheeler LRA; Tran K; Marucci D; Murrell DF
Acta Derm Venereol; 2018 Jan; 98(1):70-76. PubMed ID: 28853495
[TBL] [Abstract][Full Text] [Related]
40. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]